TY  - BOOK
AU  - 	Elias J. Anaissie
AU  - Michael R. McGinnis
AU  - Michael A. Pfaller
TI  - Clinical Mycology 
SN  - 1416056807
U1  - 616.01 
PY  - 2009///
CY  - China 
PB  - Elsevier Health Sciences
KW  -  
N1  - Contents:

SECTION ONE GENERAL PRINCIPLES INCLUDING DIAGNOSIS

SECTION TWO THE ORGANISMS

SECTION THREE CLINICAL SYNDROMES AND ORGAN SYSTEMS

SECTION FOUR SPECIAL CONSIDERATIONS

Index

N2  - The first book of its kind to focus on the diagnosis, prevention, and treatment of patients with fungal infections, this definitive reference returns in a completely revised, full-color new edition. It presents specific recommendations for understanding, controlling, and preventing fungal infections based upon underlying principles of epidemiology and infection control policy, pathogenesis, immunology, histopathology, and laboratory diagnosis and antifungal therapy. More than 560 photographs, illustrations, and tables depict conditions as they appear in real life and equip you to identify clinical manifestations with accuracy. Expanded therapy content helps you implement the most appropriate treatment quickly, and a bonus CD-ROM-featuring all of the images from the text-enables you to enhance your electronic presentations.

Includes specific recommendations for diagnosing, preventing, and treating fungal infections in various patient populations based upon underlying principles of epidemiology and infection control policy, pathogenesis, immunology, histopathology, and laboratory diagnosis and antifungal therapy.
Covers etiologic agents of disease, fungal infections in special hosts such as pediatric patients and patients with cancer and HIV, infections of specific organ systems, and more, to make you aware of the special considerations involved in certain cases.
Features clinically useful and reader-friendly practical tools-including algorithms, slides, graphs, pictorials, photographs, and radiographs-that better illustrate and communicate essential points, promote efficient use in a variety of clinical and academic settings, and facilitate slide making for lectures and presentations.
Offers a CD-ROM containing all of the book's images for use in your electronic presentations.

Offers more clinically relevant images-more than 300 in full color for the first time-to facilitate diagnosis.
Features expanded therapy-related content, including up-to-date treatment strategies and drug selection and dosing guidelines.
Includes several new sections in the chapter on fungal infections in cancer patients that reflect the formidable clinical challenges these infections continue to present.
Presents the work of additional international contributors who have defined many of the key issues in the field, providing more of a global perspective on the best diagnostic and management approaches.
Uses a new, full-color design to enhance readability and ease of access to information; Common terms and phrases:  activity acute amphotericin antibody antifungal agents antifungal therapy antigen Antimicrob Agents Chemother aspergillosis associated azoles blastomycosis blood bone marrow cancer patients Candida albicans Candida species Candida spp candidemia candidiasis capsulatum caspofungin cells chronic Clin Infect Clin Microbiol clinical Coccidioides coccidioidomycosis colonies conidia cryptococcosis Cryptococcus neoformans culture cutaneous dematiaceous dermatitidis Dermatol detection diagnosis disease disseminated dose drug echinocandins endemic epidemiology fluconazole flucytosine fungemia fungi fungus Fusarium gene granuloma hematogenous hematologic Histoplasma histoplasmosis host human hyphae immunocompromised immunodeficiency immunosuppression invasive aspergillosis invasive candidiasis invasive fungal infections involvement isolates itraconazole lesions lipid lung macrophages Malassezia marneffei meningitis micafungin Microbiol Infect molecular Mycol mycoses neonates neutropenia neutropenic neutrophils nosocomial occur opportunistic oral organism pathogenesis pediatric phaeohyphomycosis Pneumocystis pneumonia posaconazole prophylaxis pulmonary radiographic reported response risk factors serum sinusitis skin stain susceptibility syndrome systemic tinea tion tissue transplant recipients treatment Trichosporon virulence vitro voriconazole yeast zygomycosis
ER  -